UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Position in SVRA — Savara Inc

CIK 861177 NEW YORK, NY

Back to SVRA Full portfolio

Position in SVRA

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$715,926

+$428,087 QoQ

Shares Held

116,222

+120.5% QoQ

Ownership

0.057%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#73

of 181 holders

Holding Since

Mar 2024

8 quarters on record

Voting authority Sole 60% Shared 0% None 40%

Common Shares in SVRA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,385,897,555 across 206 Biotechnology names. SVRA ranks #126 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	3,086,683	$1,533,248,041
2	REGN	Regeneron Pharmaceuticals, Inc.	716,560	$446,803,817
3	ALNY	Alnylam Pharmaceuticals, Inc.	727,848	$219,104,078
4	INCY	Incyte Corp	1,508,720	$171,028,494
5	RVMD	Revolution Medicines, Inc.	912,335	$170,862,094
6	INSM	INSMED Inc	1,335,071	$142,345,265
7	IONS	Ionis Pharmaceuticals Inc	1,454,672	$115,340,938
8	MRNA	Moderna, Inc.	1,521,849	$106,575,080

All Filings in SVRA

Export CSV

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$715,926	116,222	+120.5%	Shares	Defined	2026-08-13
2026-03-31	$287,839	52,718	-76.2%	Shares	Defined	2026-05-13
2025-06-30	$505,404	221,669	+39.4%	Shares	Defined	2025-08-14
2025-03-31	$440,572	159,052	+1.3%	Shares	Defined	2025-05-19
2024-12-31	$481,935	156,983	+24.8%	Shares	Defined	2025-02-14
2024-09-30	$533,455	125,815	+5.1%	Shares	Defined	2024-11-14
2024-06-30	$482,285	119,674	+591.8%	Shares	Defined	2024-08-14
2024-03-31	$86,154	17,300	—	Shares	Defined	2024-05-15
No filing history on record for this holder in this stock.